BIOGEN PHARMACHEM INDUSTRIES LIMITED

BSE: BIOGEN531752ISIN INE703D01023

Financial Services
Other Financial Services

BSE listing

Share price

₹0.27-0.01 (-3.57%)

as of 18 Sep 2026

52W high: ₹0.92
52W low: ₹0.25
Off 52W high: -70.65%
1M return: -3.57%
3M return: -18.18%
6M return: -50.00%
1Y return: -69.66%
20D avg volume: 39,90,711
50 DMA: ₹0.29
200 DMA: ₹0.49

Key ratios Standalone

Market cap: ₹28.43 Cr
Current price: ₹0.27
52W high / low: ₹0.92 / ₹0.25
Face value: ₹1.00
P/E: —
P/B: 0.51
EPS (TTM): —
Book value / share: ₹0.53
ROE: -0.30%
ROCE: 1.00%
Operating margin: 49.89%
Net margin: 49.89%
Debt / equity: 0.00
Net debt: ₹-0.32 Cr
Interest cover: —
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 0.0 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	0.44	0.58	0.00	0.00	1.54	1.35	—
	0.00	0.00	0.54	-0.10	0.00	0.00	—
	0.22	0.94	0.08	0.39	0.20	0.17	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.02	0.10	0.07	0.05	0.06	0.09	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.20	0.83	0.01	0.34	0.13	0.08	—
	0.22	-0.36	0.46	-0.49	1.34	1.18	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.22	-0.36	0.46	-0.49	1.34	1.18	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.22	-0.36	0.46	-0.49	1.34	1.18	—
	0.00	0.00	0.01	-0.01	0.01	0.02	—
Key metrics
	0.22	-0.36	0.46	-0.49	1.34	1.18	—
	50.00%	-62.10%	—	—	87.00%	87.40%	—
	50.00%	-62.10%	—	—	87.00%	87.40%	—
	—	-0.40%	—	-0.50%	—	1.30%	—
	-71.40%	-57.00%	—	—	—	—	—
	-83.60%	-130.50%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	1.02	2.56	0.84	—
	0.44	0.00	0.00	—
	1.63	1.60	1.13	—
	0.00	0.00	0.00	—
	0.00	0.00	0.00	—
	0.24	0.28	0.17	—
	0.00	0.00	0.00	—
	0.00	0.00	0.00	—
	1.38	1.32	0.96	—
	-0.17	0.96	-0.29	—
	0.00	0.00	0.00	—
	-0.17	0.96	-0.29	—
	0.00	0.10	0.00	—
	-0.17	0.86	-0.29	—
	0.00	0.01	0.00	—
Key metrics
	-0.17	0.96	-0.29	—
	-16.67%	37.50%	-34.50%	—
	-16.67%	33.60%	-34.50%	—
	—	1.00%	-0.30%	—
	—	204.80%	—	—
	—	396.60%	—	—
	—	1.57	-1.09	—
	—	1.83	3.76	—
	—	0.00	0.00	—
	—	-0.32	-0.05	—
	—	0.0	0.0	—
Balance sheet
	—	99.40	92.02	—
	—	0.49	2.66	—
	—	0.32	0.05	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.00	0.57	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.21	0.09	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	99.09	91.93	—
Cash flow
	—	1.57	-1.09	—
	—	-9.56	-32.61	—
	—	6.30	35.70	—
	—	0.00	0.00	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 0.00%

Holder	Type	Holding	Previous	Change
OMEGA COAL PRIVATE LIMITED	Public	5.05%	—	—
PARICHAY INFRASTRUCTURE LIMITED	Public	4.27%	—	—
RAMA SHIVA LEASE FINANCE PRIVATE LIMITED	Public	3.69%	—	—
INTERFACE FINANCIAL SERVICES LIMITED	Public	3.37%	—	—
SUBHRASHI AGENCIES PRIVATE LIMITED	Public	2.45%	—	—
ANAMIKA DEALERS PRIVATE LIMITED	Public	2.45%	—	—
COMPACT FASHIONS PRIVATE LIMITED	Public	2.21%	—	—
KAMNA COAL PRIVATE LIMITED	Public	1.13%	—	—
Others	Public	0.01%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

PFA17 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial ....4 Sep 2026 · Others / Reg. 34 (1) Annual Report
PFA4 Sep 2026 · Corp. Action / Book Closure
PFA4 Sep 2026 · AGM/EGM / AGM
PFA5 Aug 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
PFA5 Aug 2026 · Result / Financial Results
Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors ....5 Aug 2026 · Board Meeting / Outcome of Board Meeting
Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Pursuant to Regulation ....21 Jul 2026 · Board Meeting / Board Meeting
PFA7 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
PFA12 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
PFA23 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rama Shiva Lease Finance Pvt Ltd20 May 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rama Shiva Lease Finance Pvt Ltd20 May 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Parichay Infrastructure Ltd20 May 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Interface Financial Services Ltd19 May 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
PFA18 May 2026 · Company Update / Allotment of Equity Shares
PFA14 May 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
PFA14 May 2026 · Result / Financial Results
This is to inform you that Outcome of the Board Meeting of the Company held on today i.e. Thursday 14th May 2026 in accordance with SEBl (Listing Obligations and Disclosures Requirements) ....14 May 2026 · Board Meeting / Outcome of Board Meeting
Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve Pursuant to Regulation ....4 May 2026 · Board Meeting / Board Meeting
PFA27 Apr 2026 · Company Update / Amendments to Memorandum & Articles of Association
Results of Postal Ballot Notice Dated 23rd March 202627 Apr 2026 · AGM/EGM / Postal Ballot
PFA27 Apr 2026 · AGM/EGM / Postal Ballot
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....22 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
PFA6 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
PFA1 Apr 2026 · Corp. Action / Record Date
PFA25 Mar 2026 · AGM/EGM / Postal Ballot
PFA24 Mar 2026 · Company Update / General
PFA23 Mar 2026 · Company Update / General
Pursuant to Second proviso to Regulation 30(6) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that ....23 Mar 2026 · Board Meeting / Outcome of Board Meeting
PFA17 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/03/2026 ,inter alia, to consider and approve issue of bonus ....24 Feb 2026 · Board Meeting / Board Meeting
PFA11 Feb 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
PFA11 Feb 2026 · Result / Financial Results
Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors ....11 Feb 2026 · Board Meeting / Outcome of Board Meeting
APPOINTMENT OF STATUTORY AUDITOR TO FILL THE CASUAL VACNACY.10 Feb 2026 · Company Update / Appointment of Statutory Auditor/s
PFA9 Feb 2026 · Company Update / Resignation of Statutory Auditors
Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve Pursuant to regulation ....3 Feb 2026 · Company Update / Board Meeting Rescheduled
PFA3 Feb 2026 · Company Update / General
Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consider and approve Pursuant to Regulation ....19 Jan 2026 · Board Meeting / Board Meeting

Corporate actions

Purpose	Ex date	Record date	Payment date
Bonus issue 1:6	15 May 2026	15 May 2026	—

Board meetings

5 Aug 2026 Board Meeting - Financial Results